Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pradaxa hit with pre-treatment screening advice
Fierce Pharma
Friday, October 28, 2011 - 11:21am
tags:
Pradaxa, Boehringer Ingelheim, bloodthinners
Gilead 3rd-quarter profit rises on greater sales of HIV drugs, including the new Complera
Yahoo/AP
Friday, October 28, 2011 - 11:09am
tags:
HIV, Complera, earnings, Gilead
Theravance reports larger 3rd-quarter loss as lung disease drug research costs grow
Yahoo/AP
Friday, October 28, 2011 - 11:08am
tags:
earnings, Theravance
1 Biotech To Buy And 6 FDA Decision-Pending Biotechs To Avoid
Seeking Alpha
Friday, October 28, 2011 - 11:07am
tags:
Celgene, Pacira, Incyte, BioSante, Regeneron, Transcept, Antares
United Therapeutics says 3Q profit doubles
Yahoo/AP
Friday, October 28, 2011 - 10:54am
tags:
earnings, United Therapeutics
Pfizer Completes Acquisition Of Icagen
Yahoo/AP
Friday, October 28, 2011 - 10:53am
tags:
Pfizer, Icagen, M&A
3 years in, Sanofi CEO has transformed drugmaker
Yahoo/AP
Friday, October 28, 2011 - 9:38am
tags:
Sanofi, Chris Viehbacher, Pharma CEOs
Merck Profit Tops Analyst Estimates on Diabetes Drug Sales
Bloomberg
Friday, October 28, 2011 - 9:35am
tags:
Merck, earnings
Vertex A Steal Based On Blockbuster Hepatitis C Drug Sales
Seeking Alpha
Friday, October 28, 2011 - 9:34am
tags:
Vertex, earnings, hepatitis C, Bristol-Myers Squibb, JNJ, Eli Lilly, Merck, SciClone, Pharmasset
ViroPharma inks $164M deal to buy orphan drug biotech
Fierce Biotech
Thursday, October 27, 2011 - 4:16pm
tags:
ViroPharma, M&A, DuoCort Pharma
Regeneron 3Q loss widens as expenses climb
MSNBC
Thursday, October 27, 2011 - 4:11pm
tags:
Regeneron, earnings
World Health Forum: New Genzyme CEO warns on perils of scale
Bizjournals.com
Thursday, October 27, 2011 - 4:09pm
tags:
Genzyme, David Meeker, Sanofi
FDA says Yaz and other new birth control drugs appear to increase blood clot risk
Yahoo/AP
Thursday, October 27, 2011 - 4:07pm
tags:
FDA, birth control pill, Yaz, Bayer
10 Promising Therapeutic Vaccines
Fierce Vaccines
Thursday, October 27, 2011 - 1:40pm
tags:
vaccines, ICT-107, glioblastoma, ImmunoCellular, VGX-3100, Inovio, cervical cancer, MAGE-A3, GSK, skin cancer, lung cancer, NeuVax, breast cancer, RXi Pharmaceuticals, Antigen Express, AE37, Nexvax2, celiac disease, ImmusanT, ADXS-HPV, head and neck cancer, Advaxis, GI-4000, GlobeImmune, pancreatic cancer, PEV7, Pevion Biotech
Swiss activists plan 'occupy' protest at Novartis chair's house
Fierce Pharma
Thursday, October 27, 2011 - 1:31pm
tags:
Novartis, Daniel Vasella, activists
Pfizer Inc. Third Quarter Earnings on the Horizon
Yahoo/Wall St. Cheat Sheet
Thursday, October 27, 2011 - 1:29pm
tags:
Pfizer, earnings
Bayer Third-Quarter Profit More Than Doubles on Demand in Emerging Markets
Bloomberg
Thursday, October 27, 2011 - 11:44am
tags:
Bayer AG, earnings
Elan Posts Profit on Tysabri Gains, Sale of Technology Unit
Bloomberg
Thursday, October 27, 2011 - 11:40am
tags:
Elan, earnings, Tysabri
Novo Nordisk Q3 net profit rises 17 percent
Yahoo/AP
Thursday, October 27, 2011 - 11:34am
tags:
Novo Nordisk, earnings
Cubist's Adolor Acquisition Aligns Well With Its Own Skill Set
Seeking Alpha
Thursday, October 27, 2011 - 11:33am
tags:
Adolor, Cubist, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.